Grants and Contributions:
Title:
LSALT Drug Development program to mitigate COVID-19 related Organ (Lung and Kidney) damage and inflammation
Agreement Number:
1003639
Agreement Value:
$4,000,000.00
Agreement Date:
Nov 1, 2022 - Mar 31, 2024
Description:
The project targets the prevention of acute organ inflammation injury in the lungs and kidneys of patients who have moderate to severe COVID-19 and other diseases. LSALT peptide is a novel drug candidate and selective dipeptidase-1 inhibitor which blocks injury in the lungs and kidneys by reducing leukocyte recruitment and inflammation in these organs.
This project focuses on completing the clinical and commercial drug development tasks needed to obtain regulatory approval for LSALT peptide. A successful project will advance the LSALT peptide as a new therapeutic that will reduce organ inflammation complications in high risk patients, increase survival rates and provide resiliency in the Canadian healthcare system for future pandemics.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M4T 2M5
Reference Number:
172-2022-2023-Q4-1003639
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
101328227
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Amendment Date
Jan 29, 2024
Recipient's Legal Name:
Arch Biopartners Inc.
Federal Riding Name:
Toronto--St. Paul's
Federal Riding Number:
35090
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: